Skip to main content
  • News & Events
  • Careers
  • Contact

Search form

Harvard SCRB

  • Research
    • Research Areas
    • Undergraduate Research
    • Graduate Student Research
    • Finding Funding
    • Keeping Your Lab Safe
  • Education
    • Graduate Students
    • Undergraduate Students
    • Teaching Opportunities
    • Education News
  • Faculty
    • Who We Are
    • News & Events
  • Administration
    • What We Can Do For You
    • Business Operations & Budget
    • Administration & Personnel
    • Education Administration
    • Faculty & Academic Affairs
    • IT/Computers
    • Laboratory Operations
    • Research Policy & Compliance
    • Sponsored Research
Research
&
Education

HSCRB is a department of Harvard University’s Faculty of Medicine and Faculty of Arts and Sciences, the first such department in the University’s history.  The ultimate goal of all our research, whether it is focused on the most basic level of cellular development or screening chemical compounds for potential drugs, is  combating disease and tissue degeneration and improving human health.  We do our research in 100,000 square feet of state-of-the- art labs in Cambridge as well as at Harvard –affiliated hospitals.

HSCRB is a department of Harvard University’s Faculty of Medicine and Faculty of Arts and Sciences, the first such department in the University’s history.  As such, it has a unique commitment to educating a broad spectrum of students, from undergraduates, to graduate, and medical students.  Learn more about our undergraduate concentration in Human Developmental and Regenerative Biology, our graduate degree program in Developmental and Regenerative Biology and other curricular offerings.


HSCRB Photo Gallery
A. Wagers and R. Lee on GDF-11 Protein
2012-2013 HSCRB tenure-track faculty search
July 26, 2012

Harvard University is recruiting tenure-track faculty for the multi-disciplinary Department of Stem Cell and Regenerative Biology (HSCRB), Harvard’s first joint Department bridging the Faculty of Arts and Sciences and the Harvard Medical School.

Potential Diabetes Breakthrough
April 25, 2013

HSCI Co-Director Doug Melton and postdoctoral fellow Peng Yi have discovered a hormone that holds promise for a dramatically more effective treatment of type 2 diabetes. The researchers believe that the hormone might also have a role in treating type 1, or juvenile, diabetes.

 
 
  • Research
  • Education
  • Faculty
  • Administration
  • News & Events
  • Careers
  • Contact
  • HSCI website
  • Harvard University website
Follow HSCRB
  • Facebook
  • Twitter
  • LinkedIn
  • RSS
© 2013 All Rights Reserved
  • Privacy and Policy